Bavarian Nordic A/S (BVNRY)
OTHER OTC:BVNRY
US Market
Holding BVNRY?
Track your performance easily

Bavarian Nordic (BVNRY) Stock Price & Analysis

156 Followers

BVNRY Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.02%0.01%99.97%
Insiders
0.01% Other Institutional Investors
99.97% Public Companies and
Individual Investors

BVNRY FAQ

What was Bavarian Nordic A/S’s price range in the past 12 months?
Bavarian Nordic A/S lowest stock price was $6.51 and its highest was $13.92 in the past 12 months.
    What is Bavarian Nordic A/S’s market cap?
    Currently, no data Available
    When is Bavarian Nordic A/S’s upcoming earnings report date?
    Bavarian Nordic A/S’s upcoming earnings report date is Nov 15, 2024 which is in 5 days.
      How were Bavarian Nordic A/S’s earnings last quarter?
      Bavarian Nordic A/S released its earnings results on Aug 22, 2024. The company reported $0.161 earnings per share for the quarter, beating the consensus estimate of N/A by $0.161.
        Is Bavarian Nordic A/S overvalued?
        According to Wall Street analysts Bavarian Nordic A/S’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bavarian Nordic A/S pay dividends?
          Bavarian Nordic A/S pays a Notavailable dividend of $0.42 which represents an annual dividend yield of N/A. See more information on Bavarian Nordic A/S dividends here
            What is Bavarian Nordic A/S’s EPS estimate?
            Bavarian Nordic A/S’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bavarian Nordic A/S have?
            Bavarian Nordic A/S has 236,501,310 shares outstanding.
              What happened to Bavarian Nordic A/S’s price movement after its last earnings report?
              Bavarian Nordic A/S reported an EPS of $0.161 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10.098%.
                Which hedge fund is a major shareholder of Bavarian Nordic A/S?
                Currently, no hedge funds are holding shares in BVNRY
                ---

                Bavarian Nordic Stock Smart Score

                Company Description

                Bavarian Nordic A/S

                Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.
                ---

                BVNRY Earnings Call

                Q2 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                SIGA Technologies
                Novavax
                Vaxart
                Ocular Therapeutix
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis